AG00I41T

21187-98-4 | 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea

AG00I41T

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	21187-98-4
Catalog Number	AG00I41T(AGN-PC-0QXQX7)
Chemical Name	1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea
EC Number	244-260-5
IUPAC Name	1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea
InChI	InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)
InChI Key	BOVGTQGAOIONJV-UHFFFAOYSA-N
MDL Number	MFCD00409893
Molecular Formula	C15H21N3O3S
Molecular Weight	323.4105
NSC Number	758673
SMILES	C1N(CC2C1CCC2)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)C
Synonyms	Diabrezide, Diaglyk, Diaikron, Diamicron, Gen Gliclazide, Gen-Gliclazide, Gliclazide, Gliklazid, Glyade, Glyclazide, Novo Gliclazide, Novo-Gliclazide, S 1702, S 852, S-1702, S-852, S1702, S852, gliclazide, 21187-98-4, Glimicron, Diamicron, Gliclazida, Nordialex, Gliclazidum [INN-Latin], Gliclazida [INN-Spanish], 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea, C15H21N3O3S, CHEBI:31654, 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea, 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea, MFCD00409893, Gliclazidum, N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide, N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea, SE-1702, Diaikron, Gliklazid, Glyclazide, S 1702, DSSTox_CID_3095, DSSTox_RID_76872, DSSTox_GSID_23095, S 852, SE 1702, Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-, N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide, Glimicron (TN), SMR000542971, SR-01000816184, 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea, EINECS 244-260-5, Mylan-Gliclazide, Diamicron MR, PMS-Gliclazide, S-852, Urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-, Urea, 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-, Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-, Gliclazide [BAN:INN:DCF:JAN], Gliclazide,(S), BRN 1657836, NCGC00016751-01, Prestwick_869, CAS-21187-98-4, 1185039-30-8, Gliclazide (Diamicron), Spectrum_001478, SpecPlus_000870, Prestwick0_000558, Prestwick1_000558, Prestwick2_000558, Prestwick3_000558, Spectrum3_001862, Spectrum4_000598, Spectrum5_000753, Gliclazide (JP17/INN), AC1L1G0Q, SCHEMBL16387, BSPBio_000635, BSPBio_003304, KBioGR_001096, KBioSS_001958, MLS001215197, MLS001304077, MLS001304118, DivK1c_006966, Gliclazide, powder, >=98%, SPECTRUM1504145, SPECTRUM1505013, SPBio_002556, BPBio1_000699, CHEMBL427216, DTXSID9023095, CTK7G8576, KBio1_001910, KBio2_001958, KBio2_004526, KBio2_007094, KBio3_002806, 1-[3-Azabicyclo[3.3.0]oct-3-yl]-3-p-toluenesulfonylurea, BOVGTQGAOIONJV-UHFFFAOYSA-N, HMS1569P17, HMS1922D15, HMS2090K16, HMS2096P17, HMS2855P09, HMS3656C22, HMS3713P17, Pharmakon1600-01504145, BCP21240, HY-B0753, Tox21_110590, ANW-43362, BBL012275, BDBM50103512, BG0208, NSC758673, s2601, SBB066074, SE1702, STK803142, AKOS003237903, AKOS016340698, Tox21_110590_1, AB05958, API0002840, CCG-213918, CS-2963, DB01120, KS-1067, MCULE-7993816491, NSC-758673, RP17658, N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide, NCGC00095107-01, NCGC00095107-02, NCGC00095107-03, NCGC00095107-04, NCGC00095107-05, NCGC00095107-06, NCGC00095107-09, NCGC00095107-10, AC-12045, AN-17308, ST076805, SBI-0052662.P002, AB0012093, AB1004595, LS-160299, AB00053165, AK00386162, FT-0626712, G0381, SW196994-3, D01599, K-6100, AB00053165-09, AB00053165_10, AB00053165_11, 187G984, A815188, I06-0117, J-013905, J-522753, SR-01000816184-2, SR-01000816184-3, SR-01000816184-4, BRD-A61154809-001-04-3, Gliclazide, British Pharmacopoeia (BP) Reference Standard, Gliclazide, European Pharmacopoeia (EP) Reference Standard, 1-[(4-methylbenzene)sulfonyl]-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea, 3-{hexahydro-1H-cyclopenta[c]pyrrol-2-yl}-1-(4-methylbenzenesulfonyl)urea, [(3-azabicyclo[3.3.0]oct-3-yl)amino]-N-[(4-methylphenyl)sulfonyl]carboxamide, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonyl-urea, 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(p-tolylsulfonyl)urea, Benzenesulfonamide,N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl-, N-(3-azabicyclo[3.3.0]oct-3-yl){[(4-methylphenyl)sulfonyl]amino}carboxamide, Diabrezide, diabezidum, diabyl, diaprel, dizalid, gliclazid, glinormax, glyzide, Diaglyk, Glyade, Novo Gliclazide, Novo-Gliclazide, Gen Gliclazide, Gen-Gliclazide, Gliclazide?, Gliclazide-d4, Diamicron (TN), Dianorm (TN), Glubitor-OD (TN), Gliclazide (JAN/INN), D0M2MR, CID3475, ACN-040058, CS-O-01580, S-1702, S1702, S852, D005907, Gliclazide, 99%, whole-cell beta-cell ATP-sensitive potassium currents blocker - 25G 25g,

Complexity	497
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	323.13g/mol
Formal Charge	0
Heavy Atom Count	22
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	323.411g/mol
Monoisotopic Mass	323.13g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	86.9A^2
Undefined Atom Stereocenter Count	2
Undefined Bond Stereocenter Count	0
XLogP3	1.5

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P301+P312+P330
UN Code	\N

Certificate of Analysis

Lot Number